Aims/Hypothesis: Evidence of the role of cytomegalovirus (CMV) infection in the pathogenesis of type 1 diabetes (T1D) has remained inconclusive. Our aim was to elucidate the possible role of CMV infection in the initiation of islet autoimmunity and in the progression to clinical T1D among children with human leukocyte antigen (HLA)-conferred T1D risk. Results: Early childhood CMV infection was inversely associated with the development of T1D during childhood. Cumulative progression to T1D was decreased in subjects with an early CMV infection (P = 0.035). In further analyses, the effect of early CMV infection on the initiation of islet autoimmunity and progression to clinical T1D were examined separately. Interestingly, early CMV infection did not affect the appearance of T1D-associated autoantibodies but a decelerating effect was observed on the progression rate from islet autoimmunity to clinical T1D (P = 0.015).
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Results: Early childhood CMV infection was inversely associated with the development of T1D during childhood. Cumulative progression to T1D was decreased in subjects with an early CMV infection (P = 0.035). In further analyses, the effect of early CMV infection on the initiation of islet autoimmunity and progression to clinical T1D were examined separately. Interestingly, early CMV infection did not affect the appearance of T1D-associated autoantibodies but a decelerating effect was observed on the progression rate from islet autoimmunity to clinical T1D (P = 0.015).
Conclusion:
Our results suggest that an early childhood CMV infection may decelerate the progression from islet autoimmunity to clinical T1D among at-risk children and may thus protect these children from progressing to T1D during childhood. More than 75% of childhood CMV infections are acquired in early childhood, transmitted typically perinatally or during the first year of life through saliva, maternal genital secretions or breast milk after reactivation of the latent virus in the mother. Thereafter, the incidence rate of CMV infection, stays rather stable until it peaks again at the age of 4 to 5 years. 4 We have earlier analyzed the association of perinatal CMV infection and the appearance of early signs of islet autoimmunity and clinical T1D in a prospective cohort of children with HLA-conferred susceptibility to T1D. 5 In that analysis, no association of perinatal CMV infection with islet autoimmunity was observed. In contrast, a trend for a protective effect of perinatal CMV infection on the development of clinical T1D was seen, but the result was statistically nonsignificant. In this study, we aimed to further clarify the role of perinatal CMV infection in the pathogenesis of T1D by analyzing samples from a larger cohort of children with HLA-associated T1D risk.
| METHODS

| Study cohort
The study subjects participated in the prospective Finnish Type 1 Diabetes Prediction and Prevention (DIPP) study. In the DIPP study, children born at three university hospitals (Turku, Tampere, and Oulu) are first screened for HLA-DR/DQ associated susceptibility to T1D. 6 Children carrying selected HLA genotypes associated with increased T1D
risk are recruited to a follow-up program that includes regular blood sampling for measurement of islet autoantibodies. In Turku, samples are collected at 3-month intervals until the age of 24 months, and thereafter at 6-month intervals. In Oulu and Tampere, samples are col- 
| Study design
The effect of perinatal CMV infection on the development of clinical T1D, and separately, on the appearance of islet autoantibodies, and on the progression rate from the initiation of islet autoimmunity, that is, appearance of islet autoantibodies, to clinical T1D was analyzed.
| Cytomegalovirus IgG-antibody measurement
CMV-specific IgG antibodies were determined from serum samples using an in-house enzyme immune assay described in detail earlier. 8 The cut-off value for positivity was set to ≥0.15 OD (optical density).
To improve accuracy, samples with absorbance readings slightly below the reliable cut-off value (0.11-0.149 OD) were excluded (n = 41) from the final statistical analyses.
| Statistical analysis
Statistical analyses were performed with SPSS statistics 23. KaplanMeier survival analysis with Log Rank test was applied to compare the effect of early CMV infection on the development of T1D, on the appearance of islet autoantibodies, and on the progression rate from the initiation of islet autoimmunity to clinical T1D. As there was no effect between early childhood CMV infection and the development of islet autoantibodies, we set out to explore whether the decreased progression to clinical T1D would be attributable to a reduced rate of progression from the initiation of autoimmunity to clinical T1D. Indeed, we observed that the progression rate In further analyses, no significant effect of early CMV infection on the appearance of a second or third autoantibody was detected: n = 59 (18.4%) vs n = 221 (21.3%) for the appearance of a second autoantibody (P = 0.207, Kaplan-Meier survival analysis) and n = 34 (10.6%) vs n = 138 (13.3%), for the appearance of third autoantibody (P = 0.107), in CMV-seropositive and -seronegative groups, respectively. We neither observed any difference between the groups in the progression rate to clinical T1D from the appearance of the second or third persistent islet autoantibody: n = 38 (64.4%) vs n = 162 (73.3%) for progression to T1D after the appearance of the second islet autoantibody (P = 0.224) and n = 25 (73.5%) vs n = 110 (79.7%) for progression to T1D after the appearance of the third islet autoantibody (P = 0.222) in CMV-seropositive and -seronegative groups, respectively.
We also tested whether CMV infection had an effect on the appearance of the islet autoantibodies (IAA, GADA, or IA-2A) separately. Early CMV infection did not affect the appearance of GADA or IA-2A (P = 0.652 and 0.224, respectively). However, a tendency for a protective effect on the appearance of IAA was observed (P = 0.072). In Western countries CMV infection is typically acquired during the perinatal period and infancy but less commonly during later childhood. 4 Early childhood is also a critical time period for the pathogenesis of T1D as most children who eventually develop the disease in childhood seroconvert to positivity for islet autoantibodies during the first 3 years of life.
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We have earlier analyzed the possible effect of early, mostly perinatal CMV infection on development of T1D in a smaller cohort of children with increased genetic risk for the disease. 5 That study did not suggest an increased risk associated with early CMV infection but instead showed a trend for a decreased risk of T1D among subjects with CMV infection. In this study, we aimed to further assess the possible effect of early-life CMV infection by analyzing an extended cohort of children participating in the DIPP study. Here, we observed a statistically significant protective effect of an early CMV infection for the development of T1D that was due to a decelerated progression rate to T1D in subjects who had already established islet autoim- Perinatal infections and microbial exposure are known to strongly affect the balance of the immune system in early life and among these CMV infection seems to be one of the strongest factors influencing the dynamics of the immune system in children. 15 Even though our study has a limitation of lacking information on confounding factors that affect microbial exposure in the perinatal period, for example, information on the route of delivery and breastfeeding, a recently published study with the same DIPP cohort observed no association between breastfeeding and the emergence of islet autoimmunity or T1D. This supports our interpretation that CMV infection is the main environmental factor behind the results observed here. 16 Our observation of the decelerating effect of early CMV infection on the progression rate of islet autoimmunity later in childhood could be caused by the strong, potentially tolerogenic immunomodulatory effect of CMV infection on T cells. The finding is in accordance with the hygiene hypothesis, which suggests that microbial exposures in early childhood stimulate immunoregulatory mechanisms that control allergic and autoimmune reactions. However, the exact immunological mechanisms behind this protective effect remain to be elucidated. Of note, we compared children with and without early CMV infection for the distribution of HLA genotypes associated with T1D but could not see any significant difference in the frequency of children positive for either DR3-DQ2, DR4-DQ8 or combination of both haplotypes between the groups (data not shown).
In conclusion, our current findings demonstrate a protective effect of CMV infection during early life on the development of clinical T1D among subjects at genetic risk for T1D. The results support the significance of the hygiene hypothesis for the pathogenesis of T1D and highlight the importance of early childhood infections for the maturation of healthy immune responses.
